599 related articles for article (PubMed ID: 26658072)
1. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
Johnsen KB; Moos T
J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
[TBL] [Abstract][Full Text] [Related]
2. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.
Johnsen KB; Bak M; Melander F; Thomsen MS; Burkhart A; Kempen PJ; Andresen TL; Moos T
J Control Release; 2019 Feb; 295():237-249. PubMed ID: 30633947
[TBL] [Abstract][Full Text] [Related]
3. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
4. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
5. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
[TBL] [Abstract][Full Text] [Related]
6. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
Gosk S; Vermehren C; Storm G; Moos T
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
[TBL] [Abstract][Full Text] [Related]
7. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
8. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.
Wiley DT; Webster P; Gale A; Davis ME
Proc Natl Acad Sci U S A; 2013 May; 110(21):8662-7. PubMed ID: 23650374
[TBL] [Abstract][Full Text] [Related]
9. Targeting the transferrin receptor for brain drug delivery.
Johnsen KB; Burkhart A; Thomsen LB; Andresen TL; Moos T
Prog Neurobiol; 2019 Oct; 181():101665. PubMed ID: 31376426
[TBL] [Abstract][Full Text] [Related]
10. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
[TBL] [Abstract][Full Text] [Related]
11. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
12. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
[TBL] [Abstract][Full Text] [Related]
13. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
14. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
[TBL] [Abstract][Full Text] [Related]
15. Apicobasal transferrin receptor localization and trafficking in brain capillary endothelial cells.
Nielsen SSE; Holst MR; Langthaler K; Christensen SC; Bruun EH; Brodin B; Nielsen MS
Fluids Barriers CNS; 2023 Jan; 20(1):2. PubMed ID: 36624498
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Nanomedicine; 2020 Aug; 28():102225. PubMed ID: 32485318
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
18. Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles.
Johnsen KB; Bak M; Kempen PJ; Melander F; Burkhart A; Thomsen MS; Nielsen MS; Moos T; Andresen TL
Theranostics; 2018; 8(12):3416-3436. PubMed ID: 29930740
[No Abstract] [Full Text] [Related]
19. Targeting liposomes with protein drugs to the blood-brain barrier in vitro.
Visser CC; Stevanović S; Voorwinden LH; van Bloois L; Gaillard PJ; Danhof M; Crommelin DJ; de Boer AG
Eur J Pharm Sci; 2005 Jun; 25(2-3):299-305. PubMed ID: 15911226
[TBL] [Abstract][Full Text] [Related]
20. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
